Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis

Patients with Cystic Fibrosis-related diabetes (CFRD) have poorer lung function than those who do not have CFRD [1], and their lung function begins to decline several years prior to the development and diagnosis of fulminant diabetes [2]. CFRD is conventionally diagnosed using the Oral Glucose Tolerance Test (OGTT) but even when the OGTT is normal, patients with CF may still demonstrate elevated glucose levels on continuous glucose monitoring (CGM) [3,4]. Using a subcutaneous probe, CGM devices record interstitial fluid glucose levels over several days.

Source: Journal of Cystic Fibrosis - February 24, 2020 Category: Respiratory Medicine Authors: Bernadette J. Prentice, Chee Y. Ooi, Charles F. Verge, Shihab Hameed, John Widger Tags: Short Communication Source Type: research